310 related articles for article (PubMed ID: 35882782)
21. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
23. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
24. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
[TBL] [Abstract][Full Text] [Related]
25. Overexpressing six-transmembrane protein of prostate 2 (STAMP2) alleviates sepsis-induced acute lung injury probably by hindering M1 macrophage polarization via the NF-κB pathway.
Ji L; Shi X; Wang G; Wu H; Hu Z
Folia Histochem Cytobiol; 2023; 61(1):34-46. PubMed ID: 36583372
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory effects of Reduning Injection on lipopolysaccharide-induced acute lung injury of rats.
Tang LP; Xiao W; Li YF; Li HB; Wang ZZ; Yao XS; Kurihara H; He RR
Chin J Integr Med; 2014 Aug; 20(8):591-9. PubMed ID: 24916807
[TBL] [Abstract][Full Text] [Related]
27. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
[TBL] [Abstract][Full Text] [Related]
28. Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats.
Li N; Song Y; Zhao W; Han T; Lin S; Ramirez O; Liang L
BMC Physiol; 2016 Dec; 16(1):7. PubMed ID: 28031043
[TBL] [Abstract][Full Text] [Related]
29. Essential oil from Cinnamomum cassia Presl bark regulates macrophage polarization and ameliorates lipopolysaccharide-induced acute lung injury through TLR4/MyD88/NF-κB pathway.
Liu F; Yang Y; Dong H; Zhu Y; Feng W; Wu H
Phytomedicine; 2024 Jul; 129():155651. PubMed ID: 38688144
[TBL] [Abstract][Full Text] [Related]
30. FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress.
Dhlamini Q; Wang W; Feng G; Chen A; Chong L; Li X; Li Q; Wu J; Zhou D; Wang J; Zhang H; Zhang JS
Mol Med; 2022 Jun; 28(1):73. PubMed ID: 35764933
[TBL] [Abstract][Full Text] [Related]
31. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
32. The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-κB and p38 MAPK signaling pathway and excessive inflammatory responses.
Chen LJ; Ding YB; Ma PL; Jiang SH; Li KZ; Li AZ; Li MC; Shi CX; Du J; Zhou HD
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2099-2108. PubMed ID: 29687869
[TBL] [Abstract][Full Text] [Related]
33. Polysaccharides from Tetrastigma Hemsleyanum Diels et Gilg attenuate LPS-induced acute lung injury by modulating TLR4/COX-2/NF-κB signaling pathway.
Wang B; Lin Y; Zhou M; Fu S; Zhu B; Chen Y; Ding Z; Zhou F
Biomed Pharmacother; 2022 Nov; 155():113755. PubMed ID: 36182735
[TBL] [Abstract][Full Text] [Related]
34. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
[TBL] [Abstract][Full Text] [Related]
35. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
[TBL] [Abstract][Full Text] [Related]
36. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
37. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
38. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
39. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
40. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
Cai J; Wang YL; Sheng XD; Zhang L; Lv X
J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]